Therapeutic potential of medicinal marijuana: an educational primer for health care professionals

Yara Mouhamed,1,* Andrey Vishnyakov,1,* Bessi Qorri,2,* Manpreet Sambi,2,* SM Signy Frank,1 Catherine Nowierski,1 Anmol Lamba,1 Umrao Bhatti,1 Myron R Szewczuk2 1Graduate Diploma & Professional Master in Medical Sciences, School of Medicine, Queen’s University, Kingston, ON, Canada...

Full description

Bibliographic Details
Main Authors: Mouhamed Y, Vishnyakov A, Qorri B, Sambi M, Frank SMS, Nowierski C, Lamba A, Bhatti U, Szewczuk MR
Format: Article
Language:English
Published: Dove Medical Press 2018-06-01
Series:Drug, Healthcare and Patient Safety
Subjects:
Online Access:https://www.dovepress.com/therapeutic-potential-of-medicinal-marijuana-an-educational-primer-for-peer-reviewed-article-DHPS
_version_ 1828487312915300352
author Mouhamed Y
Vishnyakov A
Qorri B
Sambi M
Frank SMS
Nowierski C
Lamba A
Bhatti U
Szewczuk MR
author_facet Mouhamed Y
Vishnyakov A
Qorri B
Sambi M
Frank SMS
Nowierski C
Lamba A
Bhatti U
Szewczuk MR
author_sort Mouhamed Y
collection DOAJ
description Yara Mouhamed,1,* Andrey Vishnyakov,1,* Bessi Qorri,2,* Manpreet Sambi,2,* SM Signy Frank,1 Catherine Nowierski,1 Anmol Lamba,1 Umrao Bhatti,1 Myron R Szewczuk2 1Graduate Diploma & Professional Master in Medical Sciences, School of Medicine, Queen’s University, Kingston, ON, Canada; 2Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada *These authors contributed equally to this work Abstract: With the proposed Canadian July 2018 legalization of marijuana through the ­Cannabis Act, a thorough critical analysis of the current trials on the efficacy of medicinal marijuana (MM) as a treatment option is necessary. This review is particularly important for primary care physicians whose patients may be interested in using MM as an alternative therapy. In response to increased interest in MM, Health Canada released a document in 2013 for general practitioners (GPs) as an educational tool on the efficacy of MM in treating some chronic and acute conditions. Although additional studies have filled in some of the gaps since the release of the Health Canada document, conflicting and inconclusive results continue to pose a challenge for physicians. This review aims to supplement the Health Canada document by providing physicians with a critical yet concise update on the recent advancements made regarding the efficacy of MM as a potential therapeutic option. An update to the literature of 2013 is important given the upcoming changes in legislation on the use of marijuana. Also, we briefly highlight the current recommendations provided by Canadian medical colleges on the parameters that need to be considered prior to authorizing MM use, routes of administration as well as a general overview of the endocannabinoid system as it pertains to cannabis. Lastly, we outline the appropriate medical conditions for which the authorization of MM may present as a practical alternative option in improving patient outcomes as well as individual considerations of which GPs should be mindful. The purpose of this paper is to offer physicians an educational tool that provides a necessary, evidence-based analysis of the therapeutic potential of MM and to ensure physicians are making decisions on the therapeutic use of MM in good faith. Keywords: medicinal marijuana, cannabis, endocannabinoid system, Cannabis Act, multiple sclerosis, Parkinson’s disease, Tourette’s syndrome, gastrointestinal disorders, pregnancy, epilepsy, Access to Cannabis for Medical Purposes Regulations
first_indexed 2024-12-11T09:48:28Z
format Article
id doaj.art-f3743e789353463681a4b52954b42a6f
institution Directory Open Access Journal
issn 1179-1365
language English
last_indexed 2024-12-11T09:48:28Z
publishDate 2018-06-01
publisher Dove Medical Press
record_format Article
series Drug, Healthcare and Patient Safety
spelling doaj.art-f3743e789353463681a4b52954b42a6f2022-12-22T01:12:29ZengDove Medical PressDrug, Healthcare and Patient Safety1179-13652018-06-01Volume 10456638753Therapeutic potential of medicinal marijuana: an educational primer for health care professionalsMouhamed YVishnyakov AQorri BSambi MFrank SMSNowierski CLamba ABhatti USzewczuk MRYara Mouhamed,1,* Andrey Vishnyakov,1,* Bessi Qorri,2,* Manpreet Sambi,2,* SM Signy Frank,1 Catherine Nowierski,1 Anmol Lamba,1 Umrao Bhatti,1 Myron R Szewczuk2 1Graduate Diploma & Professional Master in Medical Sciences, School of Medicine, Queen’s University, Kingston, ON, Canada; 2Department of Biomedical and Molecular Sciences, Queen’s University, Kingston, ON, Canada *These authors contributed equally to this work Abstract: With the proposed Canadian July 2018 legalization of marijuana through the ­Cannabis Act, a thorough critical analysis of the current trials on the efficacy of medicinal marijuana (MM) as a treatment option is necessary. This review is particularly important for primary care physicians whose patients may be interested in using MM as an alternative therapy. In response to increased interest in MM, Health Canada released a document in 2013 for general practitioners (GPs) as an educational tool on the efficacy of MM in treating some chronic and acute conditions. Although additional studies have filled in some of the gaps since the release of the Health Canada document, conflicting and inconclusive results continue to pose a challenge for physicians. This review aims to supplement the Health Canada document by providing physicians with a critical yet concise update on the recent advancements made regarding the efficacy of MM as a potential therapeutic option. An update to the literature of 2013 is important given the upcoming changes in legislation on the use of marijuana. Also, we briefly highlight the current recommendations provided by Canadian medical colleges on the parameters that need to be considered prior to authorizing MM use, routes of administration as well as a general overview of the endocannabinoid system as it pertains to cannabis. Lastly, we outline the appropriate medical conditions for which the authorization of MM may present as a practical alternative option in improving patient outcomes as well as individual considerations of which GPs should be mindful. The purpose of this paper is to offer physicians an educational tool that provides a necessary, evidence-based analysis of the therapeutic potential of MM and to ensure physicians are making decisions on the therapeutic use of MM in good faith. Keywords: medicinal marijuana, cannabis, endocannabinoid system, Cannabis Act, multiple sclerosis, Parkinson’s disease, Tourette’s syndrome, gastrointestinal disorders, pregnancy, epilepsy, Access to Cannabis for Medical Purposes Regulationshttps://www.dovepress.com/therapeutic-potential-of-medicinal-marijuana-an-educational-primer-for-peer-reviewed-article-DHPSMedicinal marijuanacannabisendocannabinoid systemCannabis Actmultiple sclerosisParkinson’s diseaseTourette’s syndromegastrointestinal disorderspregnancyepilepsyAccess to Cannabis for Medical Purposes Regulations
spellingShingle Mouhamed Y
Vishnyakov A
Qorri B
Sambi M
Frank SMS
Nowierski C
Lamba A
Bhatti U
Szewczuk MR
Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
Drug, Healthcare and Patient Safety
Medicinal marijuana
cannabis
endocannabinoid system
Cannabis Act
multiple sclerosis
Parkinson’s disease
Tourette’s syndrome
gastrointestinal disorders
pregnancy
epilepsy
Access to Cannabis for Medical Purposes Regulations
title Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
title_full Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
title_fullStr Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
title_full_unstemmed Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
title_short Therapeutic potential of medicinal marijuana: an educational primer for health care professionals
title_sort therapeutic potential of medicinal marijuana an educational primer for health care professionals
topic Medicinal marijuana
cannabis
endocannabinoid system
Cannabis Act
multiple sclerosis
Parkinson’s disease
Tourette’s syndrome
gastrointestinal disorders
pregnancy
epilepsy
Access to Cannabis for Medical Purposes Regulations
url https://www.dovepress.com/therapeutic-potential-of-medicinal-marijuana-an-educational-primer-for-peer-reviewed-article-DHPS
work_keys_str_mv AT mouhamedy therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT vishnyakova therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT qorrib therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT sambim therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT franksms therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT nowierskic therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT lambaa therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT bhattiu therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals
AT szewczukmr therapeuticpotentialofmedicinalmarijuanaaneducationalprimerforhealthcareprofessionals